It is hard to get excited after looking at Inogen's (NASDAQ:INGN) recent performance, when its stock has declined 30% over the past three months. It is possible that the markets have ignored the ...

Inogen's price performance has been poor this year, but a closer look at the numbers suggests that the market's negativity may be unwarranted. Management is actively taking steps to address the ...

Inogen's new management and strategy are yielding results, with better-than-expected 2024 performance and a more stable base from which to keep growing the B2B business. Despite weak DTC sales, strong ...